Objectives Human T-cell leukaemia virus type 1 (HTLV-1), an STI, is reported to be highly
prevalent in Indigenous communities in Central Australia. HTLV-1 is an incurable, chronic …

Abstract Background The Human T Lymphotropic Virus type 1 (HTLV-1) subtype C is
endemic to central Australia where each of the major sequelae of HTLV-1 infection has been …

Infection with the human T cell leukaemia virus type 1 (HTLV-1) subtype C is endemic
among Aboriginal people in central Australia. To provide insights into the risk factors for …

Background Central Australia has the highest recorded prevalence of infection with the
human T cell leukaemia virus type 1 (HTLV-1) worldwide. Each of the clinical diseases …

Background. The human T‐cell lymphotropic virus types 1 and 2 (HTLV 1/2) are retroviruses
associated with different pathologies. HTLV‐1 causes adult T‐cell leukemia/lymphoma …

We report on the epidemiology of HTLV in England and Wales (E&W) over the past decade.
HTLV diagnoses in E&W are reported to PHE by clinicians, laboratories and NHS Blood and …

Human T-lymphotropic virus type 1 (HTLV-1) is hyperendemic amongst Indigenous
Australians living in Central Australia. The epidemiology of the disease is poorly defined in …

Abstract Objectives Estimate HTLV-1/2 (human T-cell lymphotropic viruses) prevalence in
Canadian blood donors and the association of demographic variables with infection and …

Human T-cell lymphotropic virus type-1 (HTLV-1) has a large global burden and in some key
communities, such as Indigenous Australians living in remote areas, greater than 45% of …

Introduction In resource-poor areas, infectious diseases may be important causes of
morbidity among individuals infected with the Human T-Lymphotropic Virus type 1 (HTLV-1) …